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Background
We have previously found that the novel tetramethyl-
naphthalene derivative TMNAA selectively inhibits the
proliferation of HTLV-1-infected T-cell lines but not
HTLV-1-uninfected T-cell lines. Although its target
molecule is still unknown, TMNAA did not affect NF-
B activity. Therefore, we further examined the anti-
proliferative activity of TMNAA against various T-cell
lines in combination with cepharanthine (CEP), which is
known to inhibit NF-B.
Materials and methods
HTLV-1-infected and uninfected T-cell lines were cul-
tured in the presence of various concentrations of
TMNAA and CEP, and their proliferation and viability
were determined by a tetrazolium dye method. The
mode of cell death was also examined by flow cytometry
and Western blot analysis.
Results
The 50% inhibitory concentrations (IC50s) of TMNAA
and CEP for the ATL cell line (S1T) were 1.65 ± 0.03
and 1.97 ± 0.29 µM, respectively. On the other hand,
the IC50 of TMNAA and CEP combination resulted in
0.93 ± 0.13 µM, indicating that the combination syner-
gistically inhibited the proliferation of S1T cells. Such
synergism was observed for another infected cell line
(MT-2) but not for HTLV-1-uninfected cell lines. More-
over, TMNAA did not induce apoptosis of S1T cells,
but CEP did. Interestingly, TMNAA significantly
enhanced the CEP-induced apoptosis of S1T and MT-2
cells.
Conclusions
The combination of TMNAA and CEP selectively inhi-
bits the proliferation of HTLV-1-infected cell lines
through the induction of apoptosis. Therefore, TMNAA
and CEP may have potential for chemotherapy of ATL.
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